Brent Warner - Net Worth and Insider Trading

Brent Warner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brent Warner owns 1 companies in total, including Poseida Therapeutics Inc (PSTX) .

Click here to see the complete history of Brent Warner’s form 4 insider trades.

Insider Ownership Summary of Brent Warner

Ticker Comapny Transaction Date Type of Owner
PSTX Poseida Therapeutics Inc 2022-02-21 President & Gene Therapy

Brent Warner Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brent Warner Ownership Network

Ownership Network List of Brent Warner

No Data

Ownership Network Relation of Brent Warner

Insider Network Chart

Brent Warner Owned Company Details

What does Poseida Therapeutics Inc do?

Who are the key executives at Poseida Therapeutics Inc?

Brent Warner is the President & Gene Therapy of Poseida Therapeutics Inc. Other key executives at Poseida Therapeutics Inc include President & Cell Therapy Kristin Yarema , 10 percent owner Malin Life Sciences Holdings Ltd , and director & 10 percent owner & Chief Executive Officer Eric Ostertag .

Poseida Therapeutics Inc (PSTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Poseida Therapeutics Inc Insider Transactions

No Available Data

Brent Warner Mailing Address

Above is the net worth, insider trading, and ownership report for Brent Warner. You might contact Brent Warner via mailing address: C/o Poseida Therapeutics, Inc., 9390 Towne Centre Drive, Suite 200, San Diego Ca 92121.

Discussions on Brent Warner

No discussions yet.